Skip to content

Drug interactions

Apalutamide + Daunorubicin

Severity: Minor

Apalutamide and Daunorubicin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide may modestly lower daunorubicin exposure, potentially reducing its antileukemic effect. The clinical relevance is uncertain and theoretical.

What this interaction means in plain words

Apalutamide and Daunorubicin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Apalutamide belongs to Endocrine; Daunorubicin belongs to Oncology.

Evidence level: Low

Why it happens

Possible induction of efflux transporters such as BCRP/P-gp by apalutamide, though daunorubicin's dependence on them is not well established.

What to do

No routine change is needed; monitor treatment response.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Daunorubicin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Daunorubicin?

MediHelp rates the interaction as minor. Apalutamide and Daunorubicin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Apalutamide may modestly lower daunorubicin exposure, potentially reducing its antileukemic effect. The clinical relevance is uncertain and theoretical.

How serious is the interaction between Apalutamide and Daunorubicin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed; monitor treatment response.

What other medicines interact with Apalutamide?

MediHelp also lists interactions of Apalutamide with, for example, Cabotegravir, Cobicistat, Doravirine. The full list is on the Apalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in